Another study showed that overexpression of CerS1 improved growth inhibitory effects of combination treatment of chemotherapy drugs gemcitabine and doxorubicin (GEM/DOX) in HNSCC cell line UM-SCC-22A [104]. The gene discussed is CERS1; the disease is head and neck squamous cell carcinoma.